- Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
Manabu Seino et al, 2018, Oncotarget CrossRef - Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer
Yurou Chen et al, 2024, Nature Communications CrossRef - Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
Lesley Jia Wei Pua et al, 2022, International Journal of Molecular Sciences CrossRef - The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
Yingyu Dou et al, 2019, Journal of Ovarian Research CrossRef - Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
Chunqiu Yu et al, 2020, Journal of Medicinal Chemistry CrossRef - Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
Yi‐Nan Liu et al, 2019, International Journal of Cancer CrossRef - Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling Pathway
Hanjie Yi et al, 2022, Journal of Oncology CrossRef - Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15
Hirotaka Nishi et al, 2023, Gynecologic Oncology Reports CrossRef - The role of endolysosomal trafficking in anticancer drug resistance
Noor A. Hussein et al, 2021, Drug Resistance Updates CrossRef - Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
Kathleen Wantoch von Rekowski et al, 2020, International Journal of Molecular Sciences CrossRef - Exploiting Nanocarriers for Combination Cancer Therapy
Yi Wen Kong et al, 2016, Intracellular Delivery III CrossRef - Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
Ji Hee Ha et al, 2016, Oncotarget CrossRef - Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
Zilan Zhou et al, 2017, Molecular Pharmaceutics CrossRef - Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al, 2020, International Journal of Molecular Sciences CrossRef - Inhibition of c-Jun N-terminal kinase signaling promotes osteoblastic differentiation of periodontal ligament stem cells and induces regeneration of periodontal tissues
Hiroshi Kaneko et al, 2022, Archives of Oral Biology CrossRef - xCT inhibitor sulfasalazine depletes paclitaxel‑resistant tumor cells through ferroptosis in uterine serous carcinoma
Akiko Sugiyama et al, 2020, Oncology Letters CrossRef - Antitumor activity of gemcitabine against high-grade meningiomain vitroandin vivo
Hiroyuki Takeda et al, 2017, Oncotarget CrossRef